Use of erythropoietin before the initiation of dialysis and its impact on mortality

American Journal of Kidney Diseases

Volumn 37, Issue 2, 2001, Pages 348-355

  Fink, Jeffrey C ^a   Blahut, Steven A ^a   Reddy, Manoj ^a   Light, Paul D ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Chronic renal insufficiency; Dialysis; Erythropoietin; Mortality

Indexed keywords

ERYTHROPOIETIN;

ADULT; ANEMIA; ARTICLE; DIALYSIS; FEMALE; HUMAN; KIDNEY DISEASE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; RETROSPECTIVE STUDY; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 0035147487     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/ajkd.2001.21305     Document Type: Article

References (16)

1. Prevalent left ventricular hypertrophy in the pre-dialysis population: Identifying opportunities for intervention
2. The anemia of chronic renal failure: Pathophysiology and the effects of recombinant erythropoietin
3. Impact of LVH on survival in end-stage renal disease
4. Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease
5. Double-blind, placebo controlled study of the therapeutic use of recombinant human erythropoietin for anemia associated with chronic renal failure in pre-dialysis patients
6. The use of recombinant human erythropoietin in the correction of anemia in pre-dialysis patients and its effect on renal function: A double-blind placebo-controlled trial
7. Recombinant human erythropoietin treatment in pre-dialysis patients: A double-blind placebo-controlled trial
8. Cardiovascular effect of normalizing the hematocrit level during erythropoietin therapy in pre-dialysis patients with chronic renal failure
9. Treatment of the anemia of progressive renal failure with recombinant human erythropoietin
10. Effectiveness and safety of recombinant human erythropoietin in the treatment of anemia in non dialysis patients
11. The long-term effects of recombinant erythropoietin on the cardiovascular system
12. Level of renal function at the initiation of dialysis in the US end stage renal disease population
13. Significance of serum creatinine values in new end-stage renal disease patients
14. Prevalence and factors associated with the suboptimal care before initiation of dialysis in the United States